Cancer BiologybioRxivPreprint
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers
Declan Bennett, Monika Wierdl, S Chakraborty…·Lillian M. Guenther
The paper develops ALTitude, a machine learning model to predict ALT status from whole genome sequencing data, identifies SMARCAL1 as a therapeutic target in ALT-driven cancers.